NeuroPace, Inc.
NPCE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 16.3% | 4.4% | 4.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 77.4% | 77.1% | 77% | 75.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9% | -26% | -17.6% | -12.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -12.8% | -36.8% | -29.3% | -24.5% |
| EPS Diluted | -0.11 | -0.26 | -0.21 | -0.18 |
| % Growth | 57.7% | -23.8% | -16.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |